Hosted Reception Engager in Partnership with Personalis
7:15 pm - Wednesday 7th October 2026
Establishing a Robust Framework for Tumor-Informed ctDNA Testing Solid Tumors for Patient Selection, Stratification & CDx Development
- Diagnostic partner selection for CDx development
- Transitioning translational programs to patient selection and stratification
- How ctDNA is evolving as a clinical biomarker
- Regulatory and quality hurdles for ultrasensitive ctDNA assays